Abstract Details
|
Marcus D'Souza, MD
(University-Hospital-Basel)
PRESENTER |
Dr. D'Souza has nothing to disclose. |
| Roland John | No disclosure on file |
| Heiko Rust | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Johannes Lorscheider | The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Johannes Lorscheider has received research support from Innosuisse - Swiss Innvation Ageny. The institution of Johannes Lorscheider has received research support from MSBase Foundation. The institution of Johannes Lorscheider has received research support from Novartis. |
| Shauna Gysin (Neurostatus Systems AG) | No disclosure on file |
| Brian Hunter, PhD (Novartis Pharma AG) | Brian Hunter has received personal compensation for serving as an employee of Novartis. Brian Hunter has received stock or an ownership interest from Novartis. |
| Erik Wallstroem, MD, PhD (Sanofi) | Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) | Dr. Kappos has nothing to disclose. |